Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2013
10/08/2013CA2486307C Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
10/08/2013CA2479304C Virus-like particles of human papillomavirus
10/08/2013CA2473938C Human adam-10 inhibitors
10/08/2013CA2380753C Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor
10/08/2013CA2359244C .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
10/08/2013CA2353867C Anticancer agents based on prevention of protein prenylation
10/08/2013CA2238893C Il-13 receptor polypeptide
10/03/2013WO2013149159A1 Anti-lgr5 antibodies and immunoconjugates
10/03/2013WO2013149124A1 Small molecule inhibitors of mcl-1 and uses thereof
10/03/2013WO2013149064A1 Uridine diphosphate compounds as mobilizers of hematopoietic progenitor cells
10/03/2013WO2013149058A1 Monoclonal antibodies specific to human cav-1 and uses thereof
10/03/2013WO2013149026A2 Use of n-(4-((3-(2-amino-4-pyrimidinyl) -2-pyridinyl)oxy)phenyl)-4-(4-methyl -2-thienyl)-1-phthalazinamine in combination with histone deacetylase inhibitors for treatment of cancer
10/03/2013WO2013148919A1 Treatment of multiple myeloma
10/03/2013WO2013148912A1 Compounds for use in the treatment of neuroblastoma, ewing's sarcoma or rhabdomyosarcoma
10/03/2013WO2013148864A1 Curaxins for use in treating breast cancer and method for identifying patients likely to respond
10/03/2013WO2013148857A1 Triazole derivatives as hsp90 inhibitors
10/03/2013WO2013148824A1 METHODS AND COMPOSITIONS TO TREAT CANCER USING BIFUNCTIONAL SRC-3 shRNA
10/03/2013WO2013148748A1 Lactam kinase inhibitors
10/03/2013WO2013148682A1 Methods and compositions for controlled delivery of phytochemical agents
10/03/2013WO2013148649A1 Use of survivin antagonists in polyomavirus-related disease
10/03/2013WO2013148603A1 Cinnoline derivatives as as btk inhibitors
10/03/2013WO2013148584A1 Schweinfurthin analogues
10/03/2013WO2013148337A1 Methods for treating neoplasia
10/03/2013WO2013148327A1 Nipah virus envelope psuedotyped lentiviruses and methods of their use
10/03/2013WO2013148324A1 Anti-cancer polyketide compounds
10/03/2013WO2013148285A1 Methods of inhibiting cell proliferation
10/03/2013WO2013148259A1 Cancer-related extracellular matrix signatures and related methods and products
10/03/2013WO2013148258A1 Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
10/03/2013WO2013148230A1 Polyamine transport selective therapeutic agents with enhanced stability
10/03/2013WO2013148224A1 Anti-tumor properties of dickkopf 3b
10/03/2013WO2013148219A1 Anti-metatstatic agents predicated upon polyamine-macrocyclic conjugates
10/03/2013WO2013148198A1 Methods of treating cancer having an active wnt/beta - catenin pathway
10/03/2013WO2013148114A1 P300/cbp inhibitors and methods of use
10/03/2013WO2013147793A1 Methods and compositions for modulating notch activity
10/03/2013WO2013147711A1 Bicyclic heterocyclic derivatives as mnk1 and mnk2 modulators and uses thereof
10/03/2013WO2013147642A1 Anti-tumour immunotherapy method
10/03/2013WO2013147630A1 Methoxy and methylthio derivatives of trans-stilbene and their use
10/03/2013WO2013147629A1 The new derivatives of (z)-1,2-diphenylethene
10/03/2013WO2013147578A1 Raw extract of a sechium edule hybrid, method for extracting same and use thereof for formulations having an antineoplastic effect
10/03/2013WO2013147513A1 Composition for preventing or treating immune-related disease and oxidative-stress-related disease
10/03/2013WO2013147509A1 Epitopes of epidermal growth factor receptor surface antigen and use thereof
10/03/2013WO2013147340A1 Composition and dietary supplement for treating lung cancer, containing frankincense extract
10/03/2013WO2013147213A1 Anti-siglec15 antibody with modified cdr
10/03/2013WO2013147212A1 Novel anti-siglec15 antibody
10/03/2013WO2013147176A1 Pharmaceutical composition for treatment and/or prevention of gall bladder cancer
10/03/2013WO2013147169A1 Pharmaceutical composition for treatment and/or prevention of liver cancer
10/03/2013WO2013147153A1 Anti-lamp5 antibody and utilization thereof
10/03/2013WO2013147135A1 Controlled-release pharmaceutical composition
10/03/2013WO2013147049A1 Novel artificial lipopeptide
10/03/2013WO2013146970A1 Novel quinoline derivative
10/03/2013WO2013146969A1 Novel disubstituted cyclohexane derivative
10/03/2013WO2013146833A1 SALT OF 1-(2-DEOXY-2-FLUORO-4-THIO-β-D-ARABINOFURANOSYL)CYTOSINE
10/03/2013WO2013146754A1 Aromatic heterocyclic five-membered ring derivative having trpv4 inhibitory activity
10/03/2013WO2013146734A1 Anticancer agent
10/03/2013WO2013146480A1 Gene introduction method
10/03/2013WO2013146437A1 3-decenoic acid derivative and use for same
10/03/2013WO2013146435A1 Agent for preventing or treating giant cell tumor or chondrosarcoma arising in bone/soft tissue
10/03/2013WO2013146380A1 Coating composition and medical device
10/03/2013WO2013146376A1 Coating composition and medical device
10/03/2013WO2013144916A1 Tranilast compositions and cocrystals
10/03/2013WO2013144894A1 Nucleoside analogue as an anticancer compound
10/03/2013WO2013144879A1 Amorphous carbon supported nanoparticles comprising oxides of lanthanides and method for preparing them
10/03/2013WO2013144616A1 Breast cancer assay
10/03/2013WO2013144532A1 3 -cyano- 5 -arylamino-7 -cycloalkylaminopyrrolo [1, 5 -a] pyrimidine derivatives and their use as antitumor agents
10/03/2013WO2013144266A1 Ang2-binding molecules
10/03/2013WO2013144249A1 Pharmaceutical diagnostic
10/03/2013WO2013144189A1 Amino-substituted imidazopyridazines
10/03/2013WO2013144083A1 4-oxo-2-pentenoic acid and the health of the digestive tract
10/03/2013WO2013143597A1 Demethylase enzymes inhibitors
10/03/2013WO2013143466A1 Substituted pyrimidine derivative as aurora kinase inhibitor
10/03/2013WO2013143412A1 Pharmaceutical compositions
10/03/2013WO2013143376A1 Quinoline compounds containing 1,2,4-triazine-3,5-dione and use thereof
10/03/2013WO2013143322A1 Method for dissolving flavonoid compound, carbon glycoside compound, or stilbene compound and method for preparing injection or powder for injection
10/03/2013WO2013143319A1 Quinazoline derivative and usage thereof
10/03/2013WO2013143300A1 Sustained-release preparation of fulvestrant or derivatives thereof and preparation method therefor
10/03/2013WO2013143299A1 Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof
10/03/2013WO2013143298A1 Fulvestrant or fulvestrant derivative oily preparation and preparation method thereof
10/03/2013WO2013143184A1 Streptomyces, and anti-tumor compounds spiro-indimycin a-d and preparation method and application thereof
10/03/2013WO2013143057A1 Quinazoline derivative and application thereof
10/03/2013WO2013143000A1 Combination therapy for the treatment of cancer
10/03/2013WO2013142982A1 Colca1 and colca2 and their use for the treatment and risk assessment of colon cancer
10/03/2013WO2013142961A1 Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis
10/03/2013WO2013142935A1 Combretastatin derivatives, pharmaceutical compositions comprising same and use of these derivatives as anti-tumour agents
10/03/2013WO2013095738A3 Monoclonal antibodies with altered affinities for human fcyri, fcyrllla, and c1q proteins
10/03/2013WO2013077921A3 Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
10/03/2013WO2013061328A9 Methods of treating cancer
10/03/2013WO2012156975A8 COMBINATIONS OF ANTI ErbB ANTIBODIES FOR THE TREATMENT OF CANCER
10/03/2013US20130261112 Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators
10/03/2013US20130261085 Method of improving response to chemotherapy by administering a phospholipid together with chemotherapeutic agents, and formulations therefor
10/03/2013US20130261084 Method of improving response to chemotherapy by administering a phospholipid together with chemotherapeutic agents, and formulations therefor
10/03/2013US20130261055 Novel N- and C- terminal substituted antagonistic analogs of GH-RH
10/03/2013US20130259905 Composition capable of inducing endoplasmic reticulum stress
10/02/2013EP2644614A2 Solid state forms of 5-azacytidine and processes for preparation thereof
10/02/2013EP2644594A1 Cancer Cell Targeting Using Nanoparticles
10/02/2013EP2644213A1 Drug-containing bioabsorbable fibers and implants
10/02/2013EP2644204A2 Combinations of an anti-HER2 antibody-drug conjugate and pertuzumab
10/02/2013EP2644203A1 Treatment of tumour diseases
10/02/2013EP2644195A1 Immunosuppressant Compounds and Compositions
10/02/2013EP2644194A2 Combinations of an anti-HER2 antibody-drug conjugate and docetaxel
10/02/2013EP2644192A1 Cancer Cell Targeting Using Nanoparticles
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 2211